Related Experiment Video
Updated: Jun 7, 2025

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Fabry Disease: A Rare Mutation With Common Clinical Presentation
Mariana Certal1, Elisabete Cerqueira1, Cátia Ribeiro1
1Internal Medicine, Unidade Local de Saúde de Trás-os-Montes e Alto Douro, Chaves, PRT.
Insights
Fabry disease, a rare genetic condition, can cause strokes in younger adults. Early diagnosis is crucial for timely enzyme replacement therapy, improving patient outcomes.
Area of Science:
- Neurology
- Genetics
- Vascular Medicine
Background:
- Strokes in young adults are uncommon, posing diagnostic challenges.
- Fabry disease is a rare genetic disorder with complex pathophysiology, potentially causing cerebrovascular events.
- The case highlights the diagnostic difficulties in identifying rare genetic causes of stroke in younger individuals.
Abstract:
Strokes are infrequent in younger adults, making diagnosis of their underlying causes challenging. Fabry disease, a rare genetic condition with a complex and not fully understood pathophysiology, is one potential cause. This report describes a 41-year-old woman with a history of glaucoma, recurrent uveitis, ischemic stroke affecting the posterior circulation, and sensorineural hearing loss. She was admitted to the emergency department with dysarthria, left facial paralysis, and sudden onset left hemiparesis. Imaging revealed an acute ischemic lesion and hypoplasia of the right vertebral artery. Genetic testing for CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) and MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) was negative, but a heterozygous c.937G>T (p.Asp313Tyr) variant in the GLA gene was detected, indicating Fabry disease. This case underscores the importance of early diagnosis, given the potential for treatment with enzyme replacement therapy.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cystic Fibrosis: Management
Sinus disease and chronic...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Rheumatic Heart Disease I: Introduction
Myocarditis II: Clinical features and Diagnostic Tests

